Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRVN | BMY | AMGN | GILD | REGN |
| Company | Trevena Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4000 | 43.97 | 274.18 | 65.32 | 889.41 |
| High | 0.4019 | 44.47 | 279.84 | 65.89 | 913.21 |
| Low | 0.3838 | 43.73 | 273.38 | 64.97 | 888.52 |
| Last | 0.3838 | 44.21 | 277.37 | 65.51 | 903.48 |
| Change | -0.0162 | +0.27 | +3.43 | +0.31 | +12.82 |
| % Change | -4.05% | +0.61% | +1.25% | +0.48% | +1.44% |
| Volume | 38,257 | 13,245,334 | 2,322,949 | 7,228,683 | 594,891 |
| 20-Day Average Volume | 336,593 | 14,065,432 | 2,242,988 | 7,433,584 | 476,575 |
| Previous Close | 0.4000 | 43.94 | 273.94 | 65.20 | 890.66 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3926 | 48.21 | 269.69 | 67.33 | 909.13 |
| 20-Day Raw Stochastic | 56.94% | 5.77% | 87.11% | 13.02% | 32.49% |
| 20-Day Relative Strength | 40.18% | 28.67% | 52.79% | 32.15% | 42.63% |
| Weighted Alpha | -67.47 | -36.23 | +14.56 | -21.43 | +17.16 |
| Today's Opinion | 100% Sell | 88% Sell | 24% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 8% Sell | 88% Sell | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.73% since 04/24/24 | -9.52% since 04/24/24 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | -0.34% since 04/24/24 |
| Low | 0.3700 on 04/25/24 | 43.73 on 05/01/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.4200 on 04/30/24 | 47.50 on 04/25/24 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 915.00 on 04/25/24 |
| 1-Month | |||||
| %Chg | -4.05% since 04/01/24 | -16.57% since 04/01/24 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | -6.79% since 04/01/24 |
| Low | 0.3001 on 04/02/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.4300 on 04/18/24 | 53.35 on 04/02/24 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -38.49% since 02/01/24 | -9.16% since 02/01/24 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | -5.67% since 02/01/24 |
| Low | 0.3001 on 04/02/24 | 43.73 on 05/01/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 0.7000 on 02/27/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -29.58% since 11/01/23 | -13.79% since 11/01/23 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | +14.18% since 11/01/23 |
| Low | 0.3001 on 04/02/24 | 43.73 on 05/01/24 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 783.57 on 11/10/23 |
| High | 0.7693 on 01/10/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,328 | 89,070,768 | 146,934,848 | 81,179,024 | 97,760,624 |
| Shares Outstanding, K | 18,321 | 2,027,100 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 3,130,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -40,290,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 180,000 | 11,865,000,000 | 8,196,000,000 | 6,686,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -7,930,000 | -11,911,000,000 | 767,000,000 | -4,170,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.10 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.06 on 04/01/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 42.51 | 14.82 | 16.36 | 23.75 |